Reduced-frequency bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed adults with HIV: a single-centre randomised phase 2 pilot trial in Spain

Authors:

Abstract
No abstract available
Funding Information
  • Institut d’Investigacions Biomèdiques August Pi i Sunyer, Universitat de Barcelona (II040141)
  • Institut d'Investigacions Biomèdiques August Pi i Sunyer
  • Instituto de Salud Carlos III (PI20/00869)
  • Instituto de Salud Carlos III (PI20/00676)
  • Instituto de Salud Carlos III (PI24/00816)

This publication has 31 references indexed in Scilit: